References
- LEVINE TS, PRICE AB: British J. Clin. Pract. (1994) 47 (6): 328–32.
- CZINN SJ et aL: Infect. Immun. (1991) 59: 2359–63.
- FENNERTY MB: Arch. Intern. Med. (1994) 154 (7):7 21-27.
- BERSTAD K, BERSTAD A: Nor. Laegeforen (1994) 114 (8): 932–34.
- EVANS DJ: Infect. Immun. (1992) 60: 2125–2127.
- FERRERO RL, LEE A: Mtcrob. Ecol. Health Dis. (1991) 4: 121–134.
- ISER JH et al.: Med. J. Aust. (1994) 160(4): 92–96.
- KREISS C, FRIEDM: Schweiz Med. Wochenschr. (1994) 124: 10:391–401.
- TELFORD JL et al.: J. Exp. Med. (1994) 179: 1653–58.
- SALASPURO M: FXS. (1994) 71: 185–95.
- RAUTELIN H et al.: J. Clin. Micro biol. (1994) 324: 1079–82.
- EL-OMAR E et al.: Gut (1993) 348: 1060–65.
- SCRIP(1994) 1949: 23.
- SUZUKI H et al.: Keio. J. Med. (1994) 431: 1–8.
- BIOCINE SCLAVO SpA, W09318150-A1 (1993).
- FONDATION POUR LA RECHERCHE DES MALADIES GAS-TRO-INTESTINALES, W09409823-A1 (1994).
- VANDERBILT UNIVERSITY, W09316723-A1 (1993).
- MEDICARB AB, W09416714 (1994).
- VANDERBLLT UNIVERSITY, W09409023-A1 (1994).
- INSTITUT PASTEUR, W09307273-A1 (1993).
- CZINN AND NEDRUD, W09320843-A1 (1993).
- AUSPHARM INTERNATIONAL LTD, AU644121-B2 (1993).
- AUSPHARM INTERNATIONAL LTD, W09322682-A1 (1993).
- SER1M RES CORP, JP100449.